Humira during 2014 remained the world’s best-selling prescription medicine; Sovaldi vaulted into second place in its first full year on the market; Harvoni is challenging Humira for the 2015 sales crown.
For a listing of the top 200 prescription medicines ranked by 2014 sales, please click on the link below: Top 200 Medicines Online 0815
Not your father’s launches The leading members of the pharmaceutical industry’s new compound class of 2013 have set a new standard for launch success. Remember when a drug that […]
For a listing of the new molecular entity U.S. launches during 2013, please click on the link below: NME 2013 Launches Online 0815
Still no Rx for patient adherence Pharma limited in what it can do, but can still have a positive impact Patient adherence remains a complex puzzle with no simple […]
By Howard Brock — Howard Brock is head of commercial models and local market strategy for Campbell Alliance. Additional contributors include Renee Selman, president, patient outcomes, Adheris Health; Andrew Aromando, […]
How Europe is turning transparency reporting from business constraint into commercial advantage By Tim Slevin and Guillaume Roussel — Tim Slevin is senior VP of global data solutions and Guillaume […]
By Saby Mitra and Jaideep Bajaj — Saby Mitra is an associate principal at ZS, and Jaideep Bajaj is chairman of ZS’s board of directors. As sales rep access […]
Facts & Figures • According to a survey by MedPanel, physicians are discussing wearables or health apps with 15 percent of their patients on average. This figure contrasts with the […]
Klick Ideas Exchange powers kickoff of BIO convention One of the highest-powered events of the BIO 2015 convention in Philadelphia did not actually take place in the convention center itself, […]
